User menu

Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.

Bibliographic reference Van Ende, Charlotte ; Van Laecke, Steven ; Marechal, Celine ; Verbeke, Francis ; Kanaan, Nada ; et. al. Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.. In: Journal of Nephrology, (2014)
Permanent URL http://hdl.handle.net/2078.1/144690
  1. Epstein Martin, McGrath Shaun, Law Florence, Proton-Pump Inhibitors and Hypomagnesemic Hypoparathyroidism, 10.1056/nejmc066308
  2. Koulouridis Ioannis, Alfayez Mansour, Tighiouart Hocine, Madias Nicolaos E., Kent David M., Paulus Jessica K., Jaber Bertrand L., Out-of-Hospital Use of Proton Pump Inhibitors and Hypomagnesemia at Hospital Admission: A Nested Case-Control Study, 10.1053/j.ajkd.2013.02.373
  3. Chen Joan, Yuan Yuhong Cathy, Leontiadis Grigorios I., Howden Colin W., Recent Safety Concerns With Proton Pump Inhibitors : , 10.1097/mcg.0b013e3182333820
  4. Cundy T., Dissanayake A., Severe hypomagnesaemia in long-term users of proton-pump inhibitors, 10.1111/j.1365-2265.2008.03194.x
  5. Kuipers MT, Thang HD, Arntzenius AB (2009) Hypomagnesaemia due to use of proton pump inhibitors: a review. Neth J Med 67:169–172
  6. Regolisti Giuseppe, Cabassi Aderville, Parenti Elisabetta, Maggiore Umberto, Fiaccadori Enrico, Severe Hypomagnesemia During Long-term Treatment With a Proton Pump Inhibitor, 10.1053/j.ajkd.2010.03.013
  7. Hoorn Ewout J., van der Hoek Joost, de Man Rob A., Kuipers Ernst J., Bolwerk Clemens, Zietse Robert, A Case Series of Proton Pump Inhibitor–Induced Hypomagnesemia, 10.1053/j.ajkd.2009.11.019
  8. Cundy Tim, Mackay Jonathan, Proton pump inhibitors and severe hypomagnesaemia : , 10.1097/mog.0b013e32833ff5d6
  9. Broeren Maarten A.C., Hypomagnesemia Induced by Several Proton-Pump Inhibitors, 10.7326/0003-4819-151-10-200911170-00016
  10. Mackay J. D., Bladon P. T., Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series, 10.1093/qjmed/hcq021
  11. Verbeke F., Marechal C., Van Laecke S., Van Biesen W., Devuyst O., Van Bortel L. M., Jadoul M., Vanholder R., Aortic Stiffness and Central Wave Reflections Predict Outcome in Renal Transplant Recipients, 10.1161/hypertensionaha.111.176594
  12. Gau Jen-Tzer, Yang Yu-Xiao, Chen Roger, Kao Tzu-Cheg, Uses of proton pump inhibitors and hypomagnesemia : GASTRIC ACID SUPPRESSANTS AND MAGNESIUM, 10.1002/pds.3224
  13. Sumukadas Deepa, Habicht Dirk, McMurdo Marion E. T., Proton Pump Inhibitors are Associated with Lower Magnesium Levels in Older People with Chronic Kidney Disease, 10.1111/j.1532-5415.2011.03808.x
  14. Danziger John, William Jeffrey H., Scott Daniel J., Lee Joon, Lehman Li-wei, Mark Roger G., Howell Michael D., Celi Leo A., Mukamal Kenneth J., Proton-pump inhibitor use is associated with low serum magnesium concentrations, 10.1038/ki.2012.452
  15. JUNE CARL H., THOMPSON CRAIG B., KENNEDY MICHAEL S., NIMS JANET, THOMAS E. DONNALL, PROFOUND HYPOMAGNESEMIA AND RENAL MAGNESIUM WASTING ASSOCIATED WITH THE USE OF CYCLOSPORINE FOR MARROW TRANSPLANTATION : , 10.1097/00007890-198506000-00009
  16. Barton Cyril H., Vaziri Nosratola D., Martin Donald C., Choi Sunny, Alikhani Shahriar, Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine, 10.1016/0002-9343(87)90900-4
  17. Vannini S.D. P., Truttmann A. C., Bianchetti M. G., Vannini S. D. P., Mazzola B. L., Rodoni L., Ferrari P., Wermuth B., Bianchetti M. G., Permanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine, 10.1111/j.1432-2277.1999.tb01208.x
  18. Navaneethan S.D., Sankarasubbaiyan S., Gross M.D., Jeevanantham V., Monk R.D., Tacrolimus-Associated Hypomagnesemia in Renal Transplant Recipients, 10.1016/j.transproceed.2006.02.077
  19. Andoh Takeshi F., Burdmann Emmanuel A., Fransechini Nora, Houghton Donald C., Bennett William M., Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506, 10.1038/ki.1996.417
  20. Morales J.M, Andrés A, Dominguez-Gil B, Sierra M.P, Arenas J, Delgado M, Casal M.C, Rodicio L, Tubular function in patients with hypokalemia induced by sirolimus after renal transplantation, 10.1016/s0041-1345(03)00224-0
  21. Morales Jose M., Wramner Lars, Kreis Henri, Durand Dominique, Campistol Josep M., Andres Amado, Arenas Joaquin, Negre Eric, Burke James T., Groth Carl G., , Sirolimus Does Not Exhibit Nephrotoxicity Compared to Cyclosporine in Renal Transplant Recipients, 10.1034/j.1600-6143.2002.20507.x
  22. Nijenhuis T., Downregulation of Ca2+ and Mg2+ Transport Proteins in the Kidney Explains Tacrolimus (FK506)-Induced Hypercalciuria and Hypomagnesemia, 10.1097/01.asn.0000113318.56023.b6
  23. Ikari Akira, Okude Chiaki, Sawada Hayato, Takahashi Tadanobu, Sugatani Junko, Miwa Masao, Down-regulation of TRPM6-mediated magnesium influx by cyclosporin A, 10.1007/s00210-007-0212-4
  24. Arthur John M., Shamim Shazia, Interaction of cyclosporine and FK506 with diuretics in transplant patients, 10.1046/j.1523-1755.2000.00169.x
  25. Alexandre C. d. S., de Braganca A. C., Shimizu M. H. M., Sanches T. R., Fortes M. A. Z., Giorgi R. R., Andrade L., Seguro A. C., Rosiglitazone prevents sirolimus-induced hypomagnesemia, hypokalemia, and downregulation of NKCC2 protein expression, 10.1152/ajprenal.90256.2008
  26. Sobiak Joanna, Kamińska Jolanta, Głyda Maciej, Duda Grażyna, Chrzanowska Maria, Effect of mycophenolate mofetil on hematological side effects incidence in renal transplant recipients, 10.1111/ctr.12164
  27. Cunningham J., Rodriguez M., Messa P., Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients, 10.1093/ndtplus/sfr166
  28. CHASE LEWIS R., SLATOPOLSKY EDUARDO, KRINSKI THOMAS, Secretion and Metabolic Efficacy of Parathyroid Hormone in Patients with Severe Hypomagnesemia, 10.1210/jcem-38-3-363
  29. Connor TB, Toskes P, Mahaffey Martin LGJ, Williams JB, Walser M (1972) Parathyroid function during chronic magnesium deficiency. Johns Hopkins Med J 131:100–117
  30. RUDE ROBERT K., OLDHAM SUSAN B., SINGER FREDERICK R., FUNCTIONAL HYPOPARATHYROIDISM AND PARATHYROID HORMONE END-ORGAN RESISTANCE IN HUMAN MAGNESIUM DEFICIENCY, 10.1111/j.1365-2265.1976.tb01947.x